Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline

Chest

Volumn 118, Issue 4, 2000, Pages 1158-1171

  Colice, Gene L ^a   Curtis, Anne ^b   Deslauriers, Jean ^c   Heffner, John ^d   Light, Richard ^e   Littenberg, Benjamin ^f   Sahn, Steven ^d   Weinstein, Robert A ^g   Yusen, Roger D ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g RUSH MEDICAL COLLEGE   (United States)

Author keywords

Empyema; Fibrinolytics; Parapneumonic effusion; Thoracentesis

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE;

ADULT; AGED; ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; CHEMICAL ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC SURGERY; EVIDENCE BASED MEDICINE; FEMALE; FIBRINOLYTIC THERAPY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; PLEURA CAVITY; PLEURA EFFUSION; PLEURA EMPYEMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK; THORACOCENTESIS; THORACOSCOPY; THORAX DRAINAGE; TREATMENT OUTCOME;

EID: 0033786687     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.4.1158     Document Type: Article

References (41)

1. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia
2. Parapneumonic effusion
3. Management of parapneumonic effusion
4. The clinician’s perspective on parapneumonic effusion and empyema
5. Attributes of ATS documents that guide clinical practice
6. Do clinical practice guidelines define good medical care?
7. Does evidence-based medicine help the development of clinical practice guidelines?
8. Pleural fluid chemical analysis in parapneumonic effusion
9. Is pH paper an acceptable, low-cost alternative to the blood gas analyzer for determining pleural fluid pH?
10. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip
11. The clinical course and management of thoracic empyema
12. The prognostic value of loculations in parapneumonic effusion
13. Parietal pleural changes in empyema: Appearances at CT
14. Pleural exudates and transudates: With contrast-enhanced CT
15. Befunde und stellenwert der computertomographie beim pleuraempyem
16. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusion
17. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection
18. A randomized trial of empyema therapy
19. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusion
20. VATS debridement versus thoracotomy in the treatment of loculated postpneumonia empyema
21. Management of empyema thoracis
22. Recent trends in empyema thoracis
23. Immediate drainage is not required for all patients with complicated parapneumonic effusion
24. Surgical treatment of nontuberculous empyema
25. The surgical management of empyema thoracis in substance abuse patients: A 5-year experience
26. Thoracoscopic debridement of empyema thoracis
27. Modern management of adult thoracic empyema
28. Pneumonia with pleural effusions
29. Treatment of spontaneous bacterial empyema thoracis
30. Decortication for chronic postpneumonic empyema
31. Early thoracotomy and decortication for nontuberculous empyema in adults with and without underlying disease
32. Early thoracotomy for empyema
33. Utility of pleural fluid analysis in predicting tube thoracostomy/decortication in parapneumonic effusion
34. Early aggressive surgical management of parapneumonic empyemas
35. Intrapleural administration of streptokinase in complicated purulent pleural effusion: A CT-guided strategy
36. Treatment of pleural empyema secondary to pneumonia: Thoracentesis regimen versus tube drainage
37. Intrapleural fibrinolytics in management of empyema thoracis
38. Nontuberculous bacterial empyema in patients with and without underlying disease
39. Empyema thoracis: A ten-year experience
40. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis
41. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema